OPTIMIZATION OF PRESENTATION AND CONSUMER CONTAINER OF ANTI-RABIES IMMUNOGLOBULIN OBTAINED FROM HORSE SERUM

OPTIMIZATION OF PRESENTATION AND CONSUMER CONTAINER OF ANTI-RABIES IMMUNOGLOBULIN OBTAINED FROM HORSE SERUM

We presented the data concerning optimization of presentation and consumer container of anti-rabies immunoglobulin obtained, from horse serum.. During the experiments, ampoules and. flasks were used for primary packaging. They were filled within 5 ml of the preparation of freeze-drying. Comparative...

Full description

Bibliographic Details
Main Authors:	N. N. Kochkalova, E. G. Abramova, A. K. Nikiforov, M. N. Kireyev, O. A. Lobovikova, L. V. Savitskaya, S. A. Badarin, S. V. Generalov, N. I. Kostyleva, N. A. Sharapova, Yu. V. Ivanov
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2012-09-01
Series:	Acta Biomedica Scientifica
Subjects:	anti-rabies immunoglobulin freeze-drying primary packaging stability
Online Access:	https://www.actabiomedica.ru/jour/article/view/1136

Similar Items

GAS CHROMATOGRAPHY TECHNIQUE OPTIMIZATION FOR CHECKING RESIDUAL ETHANOL IN THE PREPARATION OF HETEROLOGOUS ANTI-RABIES IMMUNOGLOBULIN
by: S. V. Generalov, et al.
Published: (2012-09-01)

Determination of the Molecular Parameters of Heterologous Anti-Rabies Immunoglobulin Using Gel-Filtration
by: E. G. Abramova, et al.
Published: (2010-08-01)

Production of Rabbit Anti-Rabies Immunoglobulin Using Cultural Antigen
by: S. V. Generalov, et al.
Published: (2012-04-01)

Production of Lyophilized Preparation of Anti-Rabies Immunoglobulin and Examination of Its Main Properties
by: E. G. Abramova, et al.
Published: (2011-04-01)

Cell Structures in Heterologous Anti-Rabies Immunoglobulin Production
by: S. V. Generalov, et al.
Published: (2011-08-01)

Cultural Antigen in the Technology for Anti-Rabies Immunoglobulin Obtainment from Equine Blood Serum
by: S. V. Generalov, et al.
Published: (2012-08-01)

Development of an in-house reference standard for anti-rabies immunoglobulin potency, to be used in the virus neutralisation test in a Vero cell culture
by: E. G. Abramova, et al.
Published: (2022-04-01)

Development of the scheme of obtaining antibodies to the ribonucleoprotein of attenuated rabies virus
by: Yu. K. Gavrilova, et al.
Published: (2019-11-01)

Heterologous Anti-Rabies Immunoglobulin - Results of the First Five Years of Production
by: E. G. Abramova, et al.
Published: (2010-06-01)

Bioethical Aspects of Improving the Production of Rabies Immunoglobulin in Russia
by: S. V. Generalov, et al.
Published: (2020-06-01)

F(ab’)<sub>2</sub>-Fragments of Antirabic Immunoglobulin Production Using Immobilized Pepsin
by: S. V. Generalov, et al.
Published: (2008-06-01)

Study of Anaphylactogenic Properties of F(ab')2-Fragments of Heterologous Anti-Rabies Immunoglobulin
by: S.V. Generalov, et al.
Published: (2009-04-01)

Non-Waste Alternative Technologies in the Production of Heterologous Anti-Rabies Immunoglobulin
by: I. M. Zhulidov, et al.
Published: (2011-08-01)

<i>In vitro</i> methods for rabies virus detection, and evaluation of their use in the production of rabies immunoglobulin
by: Yu. K. Gavrilova, et al.
Published: (2021-07-01)

Rabies and rabies immunobiological preparations: vaccinations Pasteur to the contemporary biotechnology
by: E. G. Abramova, et al.
Published: (2019-11-01)

Optimization of Specifications for Scaled-Up Fixed Rabies Virus Cultivation (“Moscow 3253” Strain) in Vero Cell Culture
by: S. V. Generalov, et al.
Published: (2014-06-01)

Flow cytometry for the analysis of virusneytralizing activity of antirabies serum and immunoglobulin drug
by: S. V. Generalov, et al.
Published: (2019-05-01)

Determination of the Activity of the Anti-Rabies Sera and Heterologous Anti-Rabies Immunoglobulin <i>in vitro</i> in the Dot Immunoassay
by: N. A. Sharapova, et al.
Published: (2010-02-01)

Experimental Substantiation of Cultural Technologies Introduction into Manufacturing of Anti-Rabies Immunoglobulin
by: E. G. Abramova, et al.
Published: (2016-06-01)

The Use of a Heterologous Anti-Rabies Immunoglobulin for Specific Prevention of Human Rabies
by: A. A. Movsesyants, et al.
Published: (2015-10-01)

ISOLATION OF GLICOPROTEID FROM THE FIXED RABIES VIRUS, STRAIN «MOSCOW 3253», AND CONSTRUCTING OF DOT-IMMUNOASSAY DIAGNOSTICUM ON ITS BASIS
by: N. A. Sharapova, et al.
Published: (2012-09-01)

Early Death from Rabies Despite of Receiving Immunoglobulin and Vaccine
by: Mahmood Sadeghi, et al.
Published: (2015-05-01)

Antibody and cytokine serum levels in patients subjected to anti-rabies prophylaxis with serum-vaccination
by: J. A. Ayres, et al.
Published: (2006-01-01)

Comparative Neutralization Activity of Commercial Rabies Immunoglobulin against Diverse Lyssaviruses
by: Jessica Coertse, et al.
Published: (2023-07-01)

Efficacy of 2% lignocaine medicated pad for pain alleviation during rabies immunoglobulin administration: A randomized controlled trial
by: Zinia T Nujum, et al.
Published: (2021-01-01)

Comparing recombinant human rabies monoclonal antibody (ormutivimab) with human rabies immunoglobulin (HRIG) for postexposure prophylaxis: A phase III, randomized, double-blind, non-inferiority trial
by: Xiaoqiang Liu, et al.
Published: (2023-09-01)

Efficacy Of Lyophilized Inactivated Rabies Vaccine
by: Omaima A. A. Alshamandy, et al.
Published: (2020-10-01)

Current Challenges of Preventive Vaccination Against Rabies
by: A. A. Movsesyants, et al.
Published: (2019-03-01)

Defining the volume of rabies immunoglobulins/ rabies monoclonal antibodies requirement for wound infiltration of category III animal exposures – an exploratory study
by: Ravish S. Haradanhalli, et al.
Published: (2021-12-01)

Injecting rabies immunoglobulin (RIG) into wounds only: A significant saving of lives and costly RIG
by: Omesh Kumar Bharti, et al.
Published: (2017-04-01)

Consumption of human rabies immunoglobulin (HRIG) for major animal bites in government hospitals of Sri Lanka.
by: WDNL Amarasinghe, et al.
Published: (2016-10-01)

Evaluation of the Effectiveness as to the Provision of Biological Safety of Works with Fixed Rabies Virus in the Process of Anti-Rabies Immunoglobulin Manufacturing
by: A. K. Nikiforov, et al.
Published: (2012-08-01)

Two decades of pharmacovigilance and clinical experience with highly purified rabies immunoglobulin F(ab')2 fragments
by: Elisa Reveneau, et al.
Published: (2017-03-01)

When horse serum meets dog bite
by: A. Neumayr, et al.
Published: (2016-01-01)

A dog bite study in a dog rabies-affected area in South Africa
by: Jacqueline Weyer, et al.
Published: (2020-06-01)

Epizootic characteristics of rabies and rabies assistance in the territory of the Kirov region in the years 2010-2018
by: N. A. Savinykh, et al.
Published: (2019-12-01)

Market mapping and landscape analysis of human rabies biologicals in India
by: Mysore Kalappa Sudarshan, et al.
Published: (2019-01-01)

A STUDY OF THE ULTRASTRUCTURE OF THE SURFACE OF THE TRANSPLANTABLE LINE VERO CELLS INFECTED WITH THE RABIES VIRUS (RABV, LISSAVIRUS, RHABDOVIRIDAE)
by: S. V. Generalov, et al.
Published: (2017-10-01)

Studies of Freeze-Drying of Cholera Chemical Vaccine Immunogens
by: A. V. Komissarov, et al.
Published: (2016-03-01)

Laboratory Diagnosis of Rabies. Current State and Trends in Development
by: S. V. Borisevich, et al.
Published: (2021-07-01)